HIGHLIGHTS
- who: Harry Wilton-Clark and Toshifumi Yokota from the Department of Medical Genetics, University of Alberta, Edmonton, AB T G , Canada have published the article: Recent Trends in Antisense Therapies for Duchenne Muscular Dystrophy, in the Journal: Pharmaceutics 2023, 15, 778. of /2023/
- what: This review Article aims to summarize the current state of development for antisense-based therapies for the treatment of Duchenne exploring candidates designed for both exon skipping and gene knockdown. Almost all current antisense therapies for DMD use the splice switching approach, aiming to selectively skip DMD exons adjacent to a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.